
Curavit provides decentralized clinical trial services that make participation more accessible and accelerate study timelines for biotech, academic research, and digital therapeutics sponsors. The company operates as a virtual contract research organization, combining study design, regulatory support, enrollment, consent, clinical oversight, and data analytics with its proprietary HIPAA‑compliant Stratus platform that enables a virtual central site, telehealth, remote monitoring, and direct‑to‑patient logistics. Curavit leverages AI and machine learning alongside real‑world data and validated digital health technologies to optimize recruitment, engagement, retention, and safety monitoring. Experienced principal investigators lead protocol development and regulatory submissions while the Curavit clinical team executes decentralized trial operations. Curavit targets sponsors seeking digitally enabled, inclusive DCTs that replace or augment brick‑and‑mortar sites and scale across diverse patient populations.

Curavit provides decentralized clinical trial services that make participation more accessible and accelerate study timelines for biotech, academic research, and digital therapeutics sponsors. The company operates as a virtual contract research organization, combining study design, regulatory support, enrollment, consent, clinical oversight, and data analytics with its proprietary HIPAA‑compliant Stratus platform that enables a virtual central site, telehealth, remote monitoring, and direct‑to‑patient logistics. Curavit leverages AI and machine learning alongside real‑world data and validated digital health technologies to optimize recruitment, engagement, retention, and safety monitoring. Experienced principal investigators lead protocol development and regulatory submissions while the Curavit clinical team executes decentralized trial operations. Curavit targets sponsors seeking digitally enabled, inclusive DCTs that replace or augment brick‑and‑mortar sites and scale across diverse patient populations.
What they do: Virtual contract research organization that designs and executes decentralized, digital-first clinical trials
Founded: 2019 or 2020 (sources vary)
Focus area: Digital therapeutics and decentralized clinical trials (DCTs)
Tech/product: Proprietary HIPAA-compliant Stratus platform for virtual central site, telehealth, remote monitoring, and direct-to-patient logistics
Latest disclosed funding: $5M Series A (Nov 14, 2022) led by Osage Venture Partners
Decentralized clinical trials and digital therapeutics trial execution
2019
Biotechnology
$5,000,000
Additional investors in the round included Royal Street Ventures and Narrow Gauge Ventures
“Backed by venture investors including Osage Venture Partners, Royal Street Ventures, and Narrow Gauge Ventures plus individual investors”